A composition comprising at least one polymer having the structure A-B-A′, wherein A and A′ may be the same or different and each is a degradable polyester component and wherein B is the reaction product resulting from the reaction between a diol, having one or more pendant oligomeric or polymeric groups, and A and A′. Additionally, a bioresorbable patch comprising: (a) an adhesion barrier component comprising the composition in the form of a film; and (b) an adhesive component comprising (i) at least one synthetic adhesive polymer and/or (ii) at least one polysaccharide. Also, a method of wound healing, comprising administering the composition or apply the patch to a patient.

A composition comprising at least one polymer having the structure A-B-A′, wherein A and A′ may be the same or different and each is a degradable polyester component and wherein B is the reaction product resulting from the reaction between a diol, having one or more pendant oligomeric or polymeric groups, and A and A′. Additionally, a bioresorbable patch comprising: (a) an adhesion barrier component comprising the composition in the form of a film; and (b) an adhesive component comprising (i) at least one synthetic adhesive polymer and/or (ii) at least one polysaccharide. Also, a method of wound healing, comprising administering the composition or apply the patch to a patient.

The present invention relates to the field of nanotechnology, in particular, to the production of biodegradable polymeric nanoparticles. The present invention provides a biodegradable polymeric nanoparticle made up of a block copolymer and a process for producing the same. The nanoparticles are produced without the use of any emulsifiers and have a size ranging from 30-120 nm. The methods of controlling the drug loading capacity are disclosed along with the process of producing entity-loaded nanoparticles. Compositions comprising the nanoparticles and their use in therapeutics, diagnostics and theranostics are also disclosed.

The present invention relates to the field of nanotechnology, in particular, to the production of biodegradable polymeric nanoparticles. The present invention provides a biodegradable polymeric nanoparticle made up of a block copolymer and a process for producing the same. The nanoparticles are produced without the use of any emulsifiers and have a size ranging from 30-120 nm. The methods of controlling the drug loading capacity are disclosed along with the process of producing entity-loaded nanoparticles. Compositions comprising the nanoparticles and their use in therapeutics, diagnostics and theranostics are also disclosed.

The present invention discloses a polycarboxylic acid water-reducing agent with high adaptability to temperature and a preparation method for preparing the same. The polycarboxylic acid water-reducing agent is prepared by introducing an unsaturated macromonomer D with a temperature-sensitive side chain which could be bonded to the backbone of the polycarboxylic acid through free radical polymerization. The polycarboxylic acid water-reducing agent prepared by the invention has an adsorption group density that can be automatically adjusted with the change of ambient temperature, and thereby shows similar dispersing capability and dispersion retention capability at different ambient temperatures, demonstrating high adaptability to different ambient temperatures. It can be used in a larger temperature range with a constant dosage, which is beneficial to further popularization and application of the polycarboxylic acid water-reducing agent in regions of different climates.

The present technology relates to a polymer comprising at least one ester repeating unit and one ether repeating unit for use in an electrochemical cell, particularly in electrochemical accumulators such as lithium batteries, sodium batteries, potassium batteries and lithium-ion batteries. More specifically, the use of this polymer as a solid polymer electrolyte (SPE), as a matrix for forming gel electrolytes, or as a binder in an electrode material are also contemplated.

Esters of polylactic acid, including polyethylene glycol esters of polylactic acid are disclosed. Exemplary esters of polylactic acid can be used as textile finishes. Methods of making the esters of polylactic acid via direct and transesterification reactions are also disclosed.

Esters of polylactic acid, including polyethylene glycol esters of polylactic acid, that are coupled with an acid are disclosed. Exemplary coupled esters of polylactic acid can be used as textile finishes. Methods of making the coupled esters of polylactic acid via direct and/or transesterification reactions are also disclosed.

The present invention relates to a nasolacrimal duct insertion member comprising a shape memory polymer for treatment of nasolacrimal duct obstruction/stenosis, wherein the shape memory polymer comprises a crosslinkable functional group, such that the nasolacrimal duct insertion member has a melting point suitable for implantation into a living body.

Esters of polylactic acid, including polyethylene glycol esters of polylactic acid, and esters of polyglycolic acid are disclosed. Exemplary esters of polylactic acid and/or esters of polyglycolic acid can be used as textile finishes. Methods of making the esters of polylactic acid via direct and transesterification reactions are also disclosed.